 |  |
Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login
here.
New
to Pharmacogenomics Reporter? For a trial subscription click here.
|
|
Volume 6 - Number 27 | July 2, 2008
 |
 |
| In This Week's Issue |  |
RFP, Collaboration, Product Launches: NCI, Vendors Get Busy on Antibodies
Not-for-Profit Readies to Bring Protein Chips to Medically Underserved Nations
MIT Team Develops Probe for In-Cell Protein-Protein Interaction Analysis
Recent Patents of Interest in Proteomics
Proteome Sciences, Vermillion, Applera, Applied Biosysems, Celerea, NextGen, Expression Pathology, Aushon, Proteros, Merchachem, Hybrigenics, Dualsystems
William Parrett, Jason Novi, Robert Gavin, Wilhelm Lachnit, Tim Harkness
GE Healthcare, Bio-Rad, AnaSpec
|
|
|
Features
|
KRAS Dx Market Emerges In US as ASCO Data Support Companion Testing for Colon Cancer With positive data from clinical trials presented at ASCOs annual meeting and the EMEAs recommendation to restrict two popular colorectal cancer drugs only for patients who express wildtype KRAS gene variants, it appears that diagnostic companies are not waiting around for a nod from the FDA before beginning to market KRAS testing in the US.
|
|
Elan, Wyeth Study Finds Alzheimer’s Drug Works in ApoE4 Non-Carriers Although the 18-month Phase II trial did not reach statistical significance on primary efficacy endpoints in the overall study population, post-hoc analyses showed that bapineuzumab yielded statistically significant and clinically meaningful benefits in ApoE4 non-carriers on a number of primary endpoints.
|
|
With GINA Passed, Focus Should Now Be On Educating Docs: NEJM Article With GINA signed into law, the priority now is to educate physicians and the public about their specific rights and the finer points of genetic nondiscrimination regulations, write GPPCs Kathy Hudson, Francis Collins, and NHGRIs M.K. Holohan in the New England Journal of Medicine.
|
Snippets
New Releases
Pairings
|